News about Global Pharma

Innovent Gets Second Fast Track Designation from FDA for IBI363

This designation applies to the treatment of unresectable, locally advanced, or metastatic squamous non-small cell lung cancer (sqNSCLC) that has progressed following anti-PD-(L)1 immune checkpoint inhibitor therapy and platinum-based chemotherapy.

Global Pharma | 17/02/2025 | By Aishwarya |  353

Tiger Wound Care Acquires Novo Health Care Service's Encore Surgical HealPACK Solutions

HealPACK is a convenience pack of premium line of surgical dressing products trusted by physicians nationwide. HealPACK comes with a specifically development HealPACK app that supports the prescription and insurance verification process needed to order the product.

Global Pharma | 15/02/2025 | By Manvi |  435

American Injectables Announces Strategic Leadership Appointments

Travis Allen, who has been instrumental in American Injectables' development since its founding, has been appointed CEO and Board Director. Paul Campanelli, former CEO of Endo International and Par Pharmaceutical, will transition to the role of Executive Chairman, while Kimberlee Steele, MD of North America at SHL Medical, joins as a new Board Member.

Global Pharma | 15/02/2025 | By Manvi |  175

Nexus Pharmaceuticals Secures FDA Approval for Tacrolimus Injection

Tacrolimus Injection 5 mg/mL (Single-Dose Vial) in a 10-pack will be launching soon.

Global Pharma | 15/02/2025 | By Aishwarya |  473

Alcami Appoints Tori E. Arens as President-Drug Product

In this role, Arens will lead the cGMP drug product manufacturing operations at Alcami.

Global Pharma | 15/02/2025 | By Aishwarya |  329

Aurora Pharmaceutical Announces Availability of EquiCoxib

Aurora Pharmaceutical announced the availability of EquiCoxib, the FDA-approved generic equivalent of Equioxx® (firocoxib), a non-steroidal anti-inflammatory drug (NSAID) used for pain and inflammation associated with osteoarthritis.

Global Pharma | 14/02/2025 | By Manvi |  351

Akeso Announces IND Acceptance for AK139

Akeso, Inc. announces the acceptance of its Investigational New Drug (IND) application by the China National Medical Products Administration (NMPA) for AK139, a bispecific antibody targeting IL-4Rα and ST2. AK139 is under investigation for a number of indications, including respiratory and skin diseases.

Global Pharma | 14/02/2025 | By Manvi |  712

Tillotts Pharma AG Celebrates 15 Years Anniversary as Part of Japanese Zeria Group

This commitment has also led to Tillotts in-licensing the product Dificlir™ for the treatment of Clostridioides difficile infection (CDI) in 2020, a potentially life-threatening disease.

Global Pharma | 14/02/2025 | By Aishwarya |  397

Clinigen and Essential Pharma to Improve Patient Access in JAPAC

IOPIDINE 5mg/ml is a short-term adjunctive therapy for patients with chronic glaucoma on maximally tolerated medical therapy to prevent or control intraocular pressure.

Global Pharma | 14/02/2025 | By Aishwarya |  608

JuliaHub Doubles Investment in Advanced Pharmaceutical Modeling Platform

JuliaHub simplifies complex pharmaceutical workflows by integrating analytics such as modeling and simulation in pharmacometrics.

Global Pharma | 14/02/2025 | By Aishwarya |  732